Game-changing Strategies of European Pharma Companies

  • ID: 4060470
  • Report
  • Region: Europe
  • 68 Pages
  • Frost & Sullivan
1 of 4
Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

FEATURED COMPANIES

  • AstraZeneca
  • Bayer
  • Novartis
  • Roche
  • Sanofi
  • MORE

This publisher has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyzes the dynamics catalyzing growth, profiles organizations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape.

The research covers the top 5 European pharmaceutical companies, based on their industry position. The companies included in the study are Bayer, AstraZeneca, Roche, Novartis, and Sanofi. These companies are benchmarked across 5 key growth levers, namely core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions.

Highlights of the company profiles include:

  • Company snapshot
  • Performance analysis (market revenue forecast)
  • Portfolio analysis
  • Key marketed products and patent expiry
  • SWOT analysis
  • Strategic analysis of growth levers
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca
  • Bayer
  • Novartis
  • Roche
  • Sanofi
  • MORE
1. Executive Summary
  • Key Questions this Study will Answer
2. European Pharma Ecosystem

3. 5 Big Themes for Innovation in European Pharma Companies

4. T10 European Pharma Companies

5. Strategic Growth Lever 1 - Focus on Core Areas

6. Strategic Growth Lever 2 - Digital Footprint

7. Strategic Growth Lever 3 - Value Chain Excellence

8. Strategic Growth Lever 4 - Strategic Collaborations/Alliances or Partnerships

9. Strategic Growth Lever 5 - Beyond-the-pill Services and Solutions

10. Company Profile - Bayer
  • Bayer Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiries
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers
11. Company Profile - AstraZeneca
  • AstraZeneca Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiries
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers
12. Company Profile - Novartis
  • Novartis Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiries
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers
13. Company Profile - Roche
  • Roche Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiries
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers
14. Company Profile - Sanofi
  • Sanofi Company Snapshot
  • Company Performance Analysis
  • Company Portfolio Analysis
  • Top 10 Marketed Products and Patent Expiries
  • Company SWOT Analysis
  • Strategic Analysis of Growth Levers
15. The Last Word
  • Legal Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca
  • Bayer
  • Novartis
  • Roche
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll